Kathleen Callahan

VP, Regulatory Affairs at Novavax

Ms. Callahan joined Novavax in July 2011 as director of regulatory affairs and was named executive director of regulatory affairs in April 2017. She has led the efforts to reach agreements with the United States and European regulatory agencies for CMC requirements for marketing applications and continues to prepare the CMC sections of our marketing applications. Ms. Callahan has more than 25 years of experience in vaccine development, with 16 years in regulatory affairs. She previously held positions of increasing responsibility at Baxter, GlaxoSmithKline, and PharmAthene. She received a bachelor of science degree in biology from Mount Saint Mary’s College and a master of science degree in biomedical science (biotechnology/molecular biology) from Hood College.
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.